The Asia Pacific Cardiovascular Digital Solutions Market would witness market growth of 5.8% CAGR during the forecast period (2022-2028).
The cardiac digital provider ecosystem is changing as a result of digital convergence. Reducing hospital admissions and changing care delivery paradigms are two examples of this. If cardiovascular digital solutions offer more than simply devices and give healthcare professionals and patients data-driven, clinically relevant, and actionable information, they will be competitive. The top cardiac monitoring providers will keep expanding and providing complete portfolios that include service and product solutions.
As a result, all cardiovascular performance management, clinical pathways, and other associated services will be accessible through a single portal, the cardiovascular information system (CVIS). Cloud-based CVIS applications will expand significantly in the future. They can enable comprehensive pathway management among all patient pathways by easily integrating with hospitals' existing corporate architectures. In addition to the current cardiac data analytics frameworks, including AI capabilities to support clinical decisions will encourage CVD prevention and treatment to the intended outcomes-based regime.
Given that Asia is home to half of the world's population, the management of cardiovascular disease (CVD) in the Asia Pacific region is an important public health concern. The Kingdom of Thailand, Japan, South Korea, Hong Kong, and other Asian countries and regions are known for having a higher morbidity and mortality rate from strokes than from coronary heart disease (CHD). Ischemic heart disorder (IHD) and stroke are the most common causes of CVD in Asia Pacific and account for more than half of all cardiovascular-related deaths in the region, mainly in Central, Western, & Southern Asia. Such high numbers have prompted regional governments to develop superior healthcare infrastructure, including technological solutions and other interventions.
The China market dominated the Asia Pacific Cardiovascular Digital Solutions Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $9,732.8 Million by 2028. The Japan market is estimated to grow a CAGR of 5.1% during (2022 - 2028). Additionally, The India market would experience a CAGR of 6.4% during (2022 - 2028).
Based on Service Type, the market is segmented into Unobtrusive Testing, CVD Health Informatics, Cardiac Rehab Programs and Others. Based on End-use, the market is segmented into Hospitals & Clinics, Ambulatory Care Centers and Others. Based on Deployment, the market is segmented into Cloud-Based and On-premise. Based on Components, the market is segmented into Devices and Software. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Cardiovascular Digital Solutions Market is Projected to reach USD 128.1 Billion by 2028, at a CAGR of 4.8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Apple, Inc., General Electric Company, Koninklijke Philips N.V., Verily Life Sciences LLC (Alphabet, Inc.), iRhythm Technologies, Inc., Bardy Diagnostics, Inc. (Hill-Rom Holdings Inc) (Baxter International Inc.), eviCore Healthcare (Express Scripts Holding Company) (Cigna Corporation), AliveCor, Inc., Cardiotrack, and HeartFlow, Inc.
By Service Type
By End-use
By Deployment
By Components
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 